What amount sold does Callodine Perpetual ABL Fund, LP report in Form D filings?

The latest linked filings report $176.7M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Callodine Perpetual ABL Fund, LP's most recent SEC filing?

Callodine Perpetual ABL Fund, LP's most recent Form D filing was on 2026-08-26.

How many investors does Callodine Perpetual ABL Fund, LP have?

The most recent Form D filing lists 47 investor(s).

Callodine Perpetual ABL Fund, LP

CIK: 0001940770·Pooled Investment Fund·BOSTON, MA·Limited Partnership·Founded 2022

Reported Sold

$176,705,000

Total Filings

Identified Offerings

Last Filed

Aug 26, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Aug 26, 2026Form D/A — Amendment

Reported sold: $176,705,000 · Target: Indefinite

Rule 506(b)·47 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Aug 28, 2025Form D/A — Amendment

Reported sold: $176,155,000 · Target: Indefinite

Rule 506(b)·46 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Sep 4, 2024Form D/A — Amendment

Reported sold: $140,536,912 · Target: Indefinite

Rule 506(b)·33 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Sep 11, 2023Form D/A — Amendment

Reported sold: $101,025,000 · Target: Indefinite

Rule 506(b)·15 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Oct 6, 2022Form D — New notice

Reported sold: $100,000,000 · Target: Indefinite

Rule 506(b)·1 investor·Section 3(c), Section 3(c)(7)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

80%

Latest reported sold across 1 identified offering

$176,705,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Callodine Commercial Partners, LLC

Related Person

Appears on 4 filings

Callodine Credit Management, LLC

Related Person

Appears on 4 filings

Gene Martin

Related Person

Appears on 4 filings

Stephen Rainville

Related Person

Appears on 4 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 26, 2026	Amendment	Indefinite	$176,705,000	47
Aug 28, 2025	Amendment	Indefinite	$176,155,000	46
Sep 4, 2024	Amendment	Indefinite	$140,536,912	33
Sep 11, 2023	Amendment	Indefinite	$101,025,000	15
Oct 6, 2022	New	Indefinite	$100,000,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

AVSF - Integrated Biosciences 2026, LLC

Pooled Investment Fund

Offering target: Indefinite

Filed Nov 5, 2026